(Q45713082)

15 December 2017

title

A latent contingency table approach to dose finding for combinations of two agents (English)

1 reference

15 December 2017

1 reference

Guosheng Yin

1

1 reference

15 December 2017

Ying Yuan

series ordinal

2

1 reference

15 December 2017

language of work or name

English

0 references

publication date

28 August 2008

1 reference

15 December 2017

1 reference

15 December 2017

volume

65

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

866-875

1 reference

maintained by WikiProject

15 December 2017

WikiProject Mathematics

0 references

cites work

General models for the joint action of mixtures of drugs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Cancer phase I clinical trials: efficient dose escalation with overdose control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Designs for single- or multiple-agent phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

A curve-free method for phase I clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Adaptive Rejection Metropolis Sampling within Gibbs Sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Some practical improvements in the continual reassessment method for phase I studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

A parallel phase I/II clinical trial design for combination therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Continual reassessment methods in phase I trials of the combination of two drugs in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Phase I clinical trial of weekly combined topotecan and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

An extension of the continual reassessment methods using a preliminary up-and-down design in a dose finding study in cancer patients, in order to investigate a greater range of doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Continual reassessment method: a practical design for phase 1 clinical trials in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Selecting drug combinations based on total equivalent dose (dose intensity)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Design and analysis of phase I clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Dose finding using the biased coin up-and-down design and isotonic regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Dose‐Finding with Two Agents in Phase I Oncology Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

Bayesian decision procedures for dose determining experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1541-0420.2008.01119.X

10.1111/J.1541-0420.2008.01119.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference